Determination of an endothelin receptor antagonist in rat plasma by radioimmunoassay

Author： Yuan S. Cylc D. Hsieh J.Y.-K. Matuszewski B.K.

Publisher： Elsevier

ISSN： 0731-7085

Source： Journal of Pharmaceutical and Biomedical Analysis, Vol.34, Iss.2, 2004-02, pp. : 391-397

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Bosentan: a dual endothelin receptor antagonist

By Roux Sébastien Rubin Lewis J

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 7, 2002-07 ,pp. : 991-1002

Informa Healthcare

Access to resources Recommend Favorite

Effect of combination of a tissue-type plasminogen activator and an endothelin receptor antagonist, FR139317, in the rat cerebral infarction model

By Umemura K. Ishiye M. Kosuge K. Nakashima M.

European Journal of Pharmacology, Vol. 275, Iss. 1, 1995-02 ,pp. : 17-21

Elsevier

Access to resources Recommend Favorite

The selective endothelin ET A receptor antagonist FR139317 inhibits neointimal thickening in the rat

By Takiguchi Y. Sogabe K.

European Journal of Pharmacology, Vol. 309, Iss. 1, 1996-08 ,pp. : 59-62

Elsevier

Access to resources Recommend Favorite

An orally active non-selective endothelin receptor antagonist, bosentan, markedly reduces injury in a rat model of colitis

By Hogaboam C.M. Muller M.J. Collins S.M. Hunt R.H.

European Journal of Pharmacology, Vol. 309, Iss. 3, 1996-08 ,pp. : 261-269

Elsevier

Access to resources Recommend Favorite

Endothelin A and B receptor antagonist bosentan reduces postischemic myocardial injury in the rat: critical timing of administration

By Xia Zhengyuan Kuo Kuo-Hsing McNeill John H Ansley David M

Canadian Journal of Physiology and Pharmacology, Vol. 83, Iss. 3, 2005-03 ,pp. : 259-266

NRC Research Press

Access to resources Recommend Favorite